Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Apple launches Watch-powered atrial fibrillation study

The firm's Apple Heart Study app will see it collaborate with Stanford Medicine

Apple Watch

Apple is collaborating with Stanford Medicine on a study that uses the tech firm’s smartwatch to monitor for atrial fibrillation.

The first-of-its-kind project will see the Apple Watch’s heart rate sensor used to collect heart data, with participants found to have an irregular rhythm offered a free consultation with a study doctor and an electrocardiogram (ECG) patch for additional monitoring.

Jeff Williams, Apple’s COO, said: “Every week we receive incredible customer letters about how Apple Watch has affected their lives, including learning that they have AFib. These stories inspire us and we're determined to do more to help people understand their health.

“Working alongside the medical community, not only can we inform people of certain health conditions, we also hope to advance discoveries in heart science.”

The Apple Heart Study app is available in the US App Store to adults who have an Apple Watch Series 1 or later and who are aged 22 or older.

Meanwhile, Apple is reportedly working on more advanced heart-monitoring features for future versions of the smartwatch that could see it incorporate EKG functionality.

9th January 2018

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics